The Establishment of Quantitatively Regulating Expression Cassette with sgRNA Targeting BIRC5 to Elucidate the Synergistic Pathway of Survivin with P-Glycoprotein in Cancer Multi-Drug Resistance
Quantitative analysis and regulating gene expression in cancer cells is an innovative method to study key genes in tumors, which conduces to analyze the biological function of the specific gene. In this study, we found the expression levels of Survivin protein (BIRC5) and P-glycoprotein (MDR1) in MC...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.797005/full |
_version_ | 1819172527322169344 |
---|---|
author | Changping Deng Fabiao Hu Zhangting Zhao Yiwen Zhou Yuping Liu Tong Zhang Shihui Li Wenyun Zheng Wenliang Zhang Tianwen Wang Xingyuan Ma |
author_facet | Changping Deng Fabiao Hu Zhangting Zhao Yiwen Zhou Yuping Liu Tong Zhang Shihui Li Wenyun Zheng Wenliang Zhang Tianwen Wang Xingyuan Ma |
author_sort | Changping Deng |
collection | DOAJ |
description | Quantitative analysis and regulating gene expression in cancer cells is an innovative method to study key genes in tumors, which conduces to analyze the biological function of the specific gene. In this study, we found the expression levels of Survivin protein (BIRC5) and P-glycoprotein (MDR1) in MCF-7/doxorubicin (DOX) cells (drug-resistant cells) were significantly higher than MCF-7 cells (wild-type cells). In order to explore the specific functions of BIRC5 gene in multi-drug resistance (MDR), a CRISPR/Cas9-mediated knocking-in tetracycline (Tet)-off regulatory system cell line was established, which enabled us to regulate the expression levels of Survivin quantitatively (clone 8 named MCF-7/Survivin was selected for further studies). Subsequently, the determination results of doxycycline-induced DOX efflux in MCF-7/Survivin cells implied that Survivin expression level was opposite to DOX accumulation in the cells. For example, when Survivin expression was down-regulated, DOX accumulation inside the MCF-7/Survivin cells was up-regulated, inducing strong apoptosis of cells (reversal index 118.07) by weakening the release of intracellular drug from MCF-7/Survivin cells. Also, down-regulation of Survivin resulted in reduced phosphorylation of PI3K, Akt, and mTOR in MCF-7/Survivin cells and significantly decreased P-gp expression. Previous studies had shown that PI3K/Akt/mTOR could regulate P-gp expression. Therefore, we speculated that Survivin might affect the expression of P-gp through PI3K/Akt/mTOR pathway. In summary, this quantitative method is not only valuable for studying the gene itself, but also can better analyze the biological phenomena related to it. |
first_indexed | 2024-12-22T20:08:36Z |
format | Article |
id | doaj.art-a8ed055e3e2945b482f77cb6b11a66c2 |
institution | Directory Open Access Journal |
issn | 2296-634X |
language | English |
last_indexed | 2024-12-22T20:08:36Z |
publishDate | 2022-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Cell and Developmental Biology |
spelling | doaj.art-a8ed055e3e2945b482f77cb6b11a66c22022-12-21T18:14:04ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2022-01-01910.3389/fcell.2021.797005797005The Establishment of Quantitatively Regulating Expression Cassette with sgRNA Targeting BIRC5 to Elucidate the Synergistic Pathway of Survivin with P-Glycoprotein in Cancer Multi-Drug ResistanceChangping Deng0Fabiao Hu1Zhangting Zhao2Yiwen Zhou3Yuping Liu4Tong Zhang5Shihui Li6Wenyun Zheng7Wenliang Zhang8Tianwen Wang9Xingyuan Ma10State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, ChinaState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, ChinaState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, ChinaState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, ChinaShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, ChinaShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, ChinaState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, ChinaShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, ChinaCenter of Translational Biomedical Research, University of North Carolina at Greensboro, Greensboro, NC, United StatesCollege of Life Sciences, Xinyang Normal University, Xinyang, ChinaState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, ChinaQuantitative analysis and regulating gene expression in cancer cells is an innovative method to study key genes in tumors, which conduces to analyze the biological function of the specific gene. In this study, we found the expression levels of Survivin protein (BIRC5) and P-glycoprotein (MDR1) in MCF-7/doxorubicin (DOX) cells (drug-resistant cells) were significantly higher than MCF-7 cells (wild-type cells). In order to explore the specific functions of BIRC5 gene in multi-drug resistance (MDR), a CRISPR/Cas9-mediated knocking-in tetracycline (Tet)-off regulatory system cell line was established, which enabled us to regulate the expression levels of Survivin quantitatively (clone 8 named MCF-7/Survivin was selected for further studies). Subsequently, the determination results of doxycycline-induced DOX efflux in MCF-7/Survivin cells implied that Survivin expression level was opposite to DOX accumulation in the cells. For example, when Survivin expression was down-regulated, DOX accumulation inside the MCF-7/Survivin cells was up-regulated, inducing strong apoptosis of cells (reversal index 118.07) by weakening the release of intracellular drug from MCF-7/Survivin cells. Also, down-regulation of Survivin resulted in reduced phosphorylation of PI3K, Akt, and mTOR in MCF-7/Survivin cells and significantly decreased P-gp expression. Previous studies had shown that PI3K/Akt/mTOR could regulate P-gp expression. Therefore, we speculated that Survivin might affect the expression of P-gp through PI3K/Akt/mTOR pathway. In summary, this quantitative method is not only valuable for studying the gene itself, but also can better analyze the biological phenomena related to it.https://www.frontiersin.org/articles/10.3389/fcell.2021.797005/fullsurvivinP-GlycoproteinCRISPR/Cas9-based Tet-off systemPI3K/Akt/mTOR pathwayMCF-7 cellsmulti-drug resistance |
spellingShingle | Changping Deng Fabiao Hu Zhangting Zhao Yiwen Zhou Yuping Liu Tong Zhang Shihui Li Wenyun Zheng Wenliang Zhang Tianwen Wang Xingyuan Ma The Establishment of Quantitatively Regulating Expression Cassette with sgRNA Targeting BIRC5 to Elucidate the Synergistic Pathway of Survivin with P-Glycoprotein in Cancer Multi-Drug Resistance Frontiers in Cell and Developmental Biology survivin P-Glycoprotein CRISPR/Cas9-based Tet-off system PI3K/Akt/mTOR pathway MCF-7 cells multi-drug resistance |
title | The Establishment of Quantitatively Regulating Expression Cassette with sgRNA Targeting BIRC5 to Elucidate the Synergistic Pathway of Survivin with P-Glycoprotein in Cancer Multi-Drug Resistance |
title_full | The Establishment of Quantitatively Regulating Expression Cassette with sgRNA Targeting BIRC5 to Elucidate the Synergistic Pathway of Survivin with P-Glycoprotein in Cancer Multi-Drug Resistance |
title_fullStr | The Establishment of Quantitatively Regulating Expression Cassette with sgRNA Targeting BIRC5 to Elucidate the Synergistic Pathway of Survivin with P-Glycoprotein in Cancer Multi-Drug Resistance |
title_full_unstemmed | The Establishment of Quantitatively Regulating Expression Cassette with sgRNA Targeting BIRC5 to Elucidate the Synergistic Pathway of Survivin with P-Glycoprotein in Cancer Multi-Drug Resistance |
title_short | The Establishment of Quantitatively Regulating Expression Cassette with sgRNA Targeting BIRC5 to Elucidate the Synergistic Pathway of Survivin with P-Glycoprotein in Cancer Multi-Drug Resistance |
title_sort | establishment of quantitatively regulating expression cassette with sgrna targeting birc5 to elucidate the synergistic pathway of survivin with p glycoprotein in cancer multi drug resistance |
topic | survivin P-Glycoprotein CRISPR/Cas9-based Tet-off system PI3K/Akt/mTOR pathway MCF-7 cells multi-drug resistance |
url | https://www.frontiersin.org/articles/10.3389/fcell.2021.797005/full |
work_keys_str_mv | AT changpingdeng theestablishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT fabiaohu theestablishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT zhangtingzhao theestablishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT yiwenzhou theestablishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT yupingliu theestablishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT tongzhang theestablishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT shihuili theestablishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT wenyunzheng theestablishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT wenliangzhang theestablishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT tianwenwang theestablishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT xingyuanma theestablishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT changpingdeng establishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT fabiaohu establishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT zhangtingzhao establishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT yiwenzhou establishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT yupingliu establishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT tongzhang establishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT shihuili establishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT wenyunzheng establishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT wenliangzhang establishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT tianwenwang establishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance AT xingyuanma establishmentofquantitativelyregulatingexpressioncassettewithsgrnatargetingbirc5toelucidatethesynergisticpathwayofsurvivinwithpglycoproteinincancermultidrugresistance |